UNAIDS (Joint United Nations Programme on HIV/AIDS). 2005. HIV/AIDS Prevention, Treatment and Care Among Injecting Drug Users and in Prison. Ministerial meeting on “Urgent Response to the HIV/AIDS Epidemics in the Commonwealth of Independent States,” Moscow, March 31 to April 1, 2005. [Online]. Available: http://www.unodc.org/pdf/event_2005-03-31_prisons.pdf [accessed June 30, 2006].
UNAIDS. 2006. 2006 Report on the Global AIDS Epidemic: A UNAIDS 10th Anniversary Special Edition. Geneva: UNAIDS.
UNODC (United Nations Office on Drugs and Crime). 2002. Amphetamine Type Stimulants Threaten East Asia: East Asia Now Has the Most Serious ATS Problems in the World. [Online]. Available: http://www.unodc.un.or.th/factsheet/ATSissuesplans310102.htm [accessed June 25, 2006].
UNODC. 2004. Law Enforcement. [Online]. Available: http://www.unodc.un.or.th/law/ [accessed June 30, 2006].
UNODC. 2005. 2005 World Drug Report. Vienna, Austria: UNODC.
Urbina A, Jones K. 2004. Crystal methamphetamine, its analogues, and HIV infection: Medical and psychiatric aspects of a new epidemic. Clinical Infectious Diseases. 38(6): 890–894.
USAID, UNAIDS, WHO, UNICEF, and POLICY Project. 2004. Coverage of Selected Services for HIV/AIDS Prevention, Care, and Support in Low- and Middle-Income Countries in 2003. Washington, DC: Futures Group, POLICY Project.
Vickerman P, Hickman M, Rhodes T, Watts C. 2006. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. Journal of Acquired Immune Deficiency Syndromes. 42(3):355–361.
Voluntary HIV-1 Counseling and Testing Efficacy Study Group. 2000. Efficacy of voluntary HIV-1 counseling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: A randomised trial. Lancet. 356(9224):103–112.
Wasserheit JN. 1992. Epidemiologic synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sexually Transmitted Diseases. 19:61–77.
Watters JK, Estilo MJ, Clark GL, Lorvick J. 1994. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association. 271:115–120.
Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et al. 1999. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Lancet. 353:525–535.
WHO (World Health Organization). 2003a. HIV/AIDS in Asia and the Pacific Region. Annual report. Manila, Philippines: WHO Western Pacific Regional Office.
WHO. 2003b. WHO Collaborative Study on Substitution Therapy of Opioid Dependence and HIV/AIDS. Geneva, Switzerland: WHO.
WHO. 2004a. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Guidelines on Care, Treatment and Support for Women Living with HIV/AIDS and Their Children in Resource-Constrained Settings. Geneva, Switzerland, WHO.
WHO. 2004b. Policy Brief: Reduction of HIV Transmission in Prisons. Geneva, Switzerland: WHO.
WHO. 2004c. Evidence for Action: Effectiveness of Community-Based Outreach in Preventing HIV/AIDS Among Injecting Drug Users. Geneva, Switzerland: WHO.
WHO. 2005a. Policy and Programming Guide for HIV/AIDS Prevention and Care Among Injecting Drug Users. Geneva, Switzerland: WHO.
WHO. 2005b. Evidence for Action: Effectiveness of Drug Dependence Treatment in Preventing HIV among Injecting Drug Users. Geneva, Switzerland: WHO.